These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15488561

  • 1. Fluorodeoxyglucose-PET in the management of breast cancer.
    Kumar R, Alavi A.
    Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
    [Abstract] [Full Text] [Related]

  • 2. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
    Aukema TS, Straver ME, Peeters MJ, Russell NS, Gilhuijs KG, Vogel WV, Rutgers EJ, Olmos RA.
    Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
    [Abstract] [Full Text] [Related]

  • 3. PET imaging in breast cancer.
    Bombardieri E, Crippa F.
    Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
    Yutani K, Tatsumi M, Shiba E, Kusuoka H, Nishimura T.
    J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
    [Abstract] [Full Text] [Related]

  • 7. Positron emission tomography for the diagnosis of breast cancer.
    Rosé C, Dose J, Avril N.
    Nucl Med Commun; 2002 Jul; 23(7):613-8. PubMed ID: 12089482
    [Abstract] [Full Text] [Related]

  • 8. Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
    Ohsumi S, Inoue T, Kiyoto S, Hara F, Takahashi M, Takabatake D, Takashima S, Aogi K, Takashima S.
    Breast Cancer Res Treat; 2011 Nov; 130(1):267-72. PubMed ID: 21590272
    [Abstract] [Full Text] [Related]

  • 9. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P.
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [Abstract] [Full Text] [Related]

  • 10. Preoperative FDG-PET for axillary metastases in patients with breast cancer.
    Chung A, Liou D, Karlan S, Waxman A, Fujimoto K, Hagiike M, Phillips EH.
    Arch Surg; 2006 Aug; 141(8):783-8; discussion 788-9. PubMed ID: 16924086
    [Abstract] [Full Text] [Related]

  • 11. Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
    Wu D, Gambhir SS.
    Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S55-63. PubMed ID: 12756080
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E.
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 17. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
    Gil-Rendo A, Zornoza G, García-Velloso MJ, Regueira FM, Beorlegui C, Cervera M.
    Br J Surg; 2006 Jun; 93(6):707-12. PubMed ID: 16622900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD.
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.